Researchers are excited about this new drug, a novel dual treatment showing significant results in early trials for weight reduction . It acts by targeting both pathways : GLP-1 and GIP, that , when https://emilieokvu890100.mpeblog.com/73518356/this-new-hope-for-size-loss